WebMar 7, 2024 · Vice President, Intellectual Property & Legal Affairs at Thinkcyte . Eiji is Vice President of Intellectual Property and Legal Affairs at Thinkcyte. He brings to this role more than 20 years of experience in intellec tual property and research in the biopharmaceutical industry. Prior to joining ThinkCyte, Dr. Nara served as Global Head of IP BD ... WebJul 5, 2024 · ThinkCyte has developed the Ghost Cytometry technology to achieve high-throughput and high-content single cell sorting and has been conducting collaborative …
Did you know?
WebFeb 6, 2024 · Noriko Takase has been working at Thinkcyte for 5 years. Thinkcyte is part of the Research & Development industry, and located in Japan. Thinkcyte. Location. U. Tokyo Entrepreneur Plaza 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. Description. WebAug 31, 2024 · この基盤技術を用いることで、新しい再生・細胞医薬や医療検査診断、創薬を実現させ、革新的な治療や診断に貢献することを目指す。. 「Deeper insights, better …
WebFounded Date Feb 2016. Founders Issei Sato, Ryoichi Horisaki, Sadao Ota, Waichiro Katsuda. Operating Status Active. Last Funding Type Series B. Company Type For Profit. ThinkCyte … WebFeb 28, 2024 · ThinkCyte, founded in 2016 with offices in Tokyo, Japan and San Carlos, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary ...
WebJul 2, 2024 · 日立とシンクサイトはそれぞれが得意とする技術やノウハウを用い、AIを活用した細胞分析・分離技術の実用化に向け、細胞分析・分離システムの共同開発を開始 … WebApr 10, 2024 · ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development programs. The company pioneered Ghost Cytometry, a ...
WebMay 12, 2024 · ThinkCyte, headquartered in Tokyo, Japan, is a biotechnology company, which develops innovative life science research, diagnostics, and treatments using integrated multidisciplinary technologies ...
WebMay 12, 2024 · ThinkCyte, headquartered in Tokyo, Japan, is a biotechnology company, which develops innovative life science research, diagnostics, and treatments using … the driver 2022WebDec 21, 2024 · Founder and shareholder of ThinkCyte, Inc. Has filed patent applications related to the in silico-labeled ghost cytometry method. Patent numbers PCT/JP2016/055412, PCT/JP2016/082089, PCT/JP2024/005237, PCT/US2024/36849, PCT/JP2024/013564, PCT/JP2024/013478 "This ORCID iD identifies the author of this … taykay fortniteWebFunding. ThinkCyte has raised a total of ¥5.1B in funding over 4 rounds. Their latest funding was raised on May 19, 2024 from a Series B round. ThinkCyte is funded by 11 investors. Sysmex Corporation and Sumitomo Mitsui Trust Investment are the most recent investors. tayione igWebCBO at ThinkCyte. “The high-throughput ability to characterize and isolate cell populations based on their image information without the use of markers or stains is highly compatible with cell manufacturing automation and enables stable, affordable, large-scale, high-quality standardized cell manufacturing processes.” the drivers collection showWebMay 29, 2024 · 昨年実施したSBIグループ、合同会社リアルテックジャパンを運営者とする「リアルテックファンド1号及び2号投資事業有限責任組合」及び大阪 ... tayishe ann baltysWebJun 23, 2024 · ThinkCyte, founded in 2016 and headquartered in Tokyo, Japan, is a biotechnology company that develops innovative instruments based on integrated, multidisciplinary technologies to enable life ... tay iwar love and isolationWebMay 19, 2024 · May 19, 2024, 10:00 ET. TOKYO, May 19, 2024 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today ... tayitu cultural and educational center